Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Charu Aggarwal, MD, MPH

Charu Aggarwal, MD, MPH Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Aggarwal is a Penn Medicine employed physician.

Clinical Specialties

Specialty:

  • Medicine
    • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2011
  • Internal Medicine, 2008
  • Medical Oncology, 2011

Clinical Expertise:

  • Head and Neck Cancer
  • Lung Cancer

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Lady Hardinge Medical College
Residency: SUNY at Buffalo Medical Center
Fellowship: Fox Chase Cancer Center

Memberships

American Association of Cancer Research, National American Society of Clinical Oncology, National

Hospital Affiliation

Dr. Aggarwal is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans TL, Langer CJ: Determinants of Survival in Advanced Non-Small Cell Lung Cancer in the Era of Targeted Therapies Clinical Lung Cancer : 2013.

Aggarwal, C: Nab-paclitaxel is a valuable NSCLC therapy option Community Oncology 10 (6): 2013.

Aggarwal C, Dahlberg SE, Hanna N, Kolesar J, Hirsch FR, Ramalingam SS and Schiller JH: Exploratory biomarker analyses from ECOG 4508: Three-arm randomized phase II study of carboplatin and paclitaxel in combination with cetuximab, IMC-A12, or both for advanced non-small cell lung cancer patients Journal of Clinical Oncology 31s (abstr 8106): 2013.

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans TL, Langer CJ: Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist? Lung Cancer : 2013.

Lustgarten DS, Deshpande C, Aggarwal C, Wang LC, Saloura V, Vachani A, Wang LP, Litzky L, Feldman M, Creaney J, Nowak AK, Langer CJ, Inghilleri S, Stella G, Albelda SM: Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma Journal of Thoracic Oncology Volume 8 (4) : 469–477,2013.

Aggarwal, C and Langer, CJ: Recent advances in the management of advanced Non Small Cell Lung Cancer Community Oncology 10 (4): 2013.

Aggarwal C, Meropol N J, Punt C J, Iannotti N, Saidman B H, Sabbath K D, Gabrail N Y, Picus J, Morse M A, Mitchell E, Miller M C, Cohen S J: Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 24 (2): 420-8,2013.

Aggarwal C, Ranganathan A, Lustgarten DS et al: Circulating Tumor Cells In Patients With Small Cell Lung Cancer: A Marker Of Disease Burden, Therapeutic Response, And Predictor Of Disease Relapse Journal of Thoracic Oncology : 2012.

Brady A, McNeill JD, Judy B, Evans T, Cohen RB, Langer C, Vachani A AND Aggarwal C: Survival outcome segregated by KRAS mutation status in newly diagnosed stage IV non-small cell lung cancer patients treated with first-line chemotherapy Journal of Clinical Oncology Supplement : 2012.

Ranganathan A, Schwed-Lustgarten D, Aggarwal C et al: Circulating tumor cells in patients with small cell lung cancer: a marker of disease burden, therapeutic response, and predictor of disease relapse Journal of Clinical Oncology Supplement : 2012.

Academic Contact Info

Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-207
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 662-6318
Fax: (215) 349-5326
Patient appointments: 800-789-PENN (7366)